Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer [NA]
This clinical trial update notes ongoing recruitment for a study evaluating urinary tumor DNA testing to guide cystoscopy in high-risk/non-m…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin [Phase 3]
Phase 3 study of Cretostimogene in non-muscle invasive bladder cancer unresponsive to BCG; the trial is currently ACTIVE_NOT_RECRUITING.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Studying the Relationship of Patient Positioning and Intravesical Bacillus Calmette Guerin Dwell Time to Improve the Treatment of Non-muscle Invasive Bladder Cancer [Phase 4]
A Phase 4 clinical trial in recruitment evaluating how patient positioning and intravesical dwell time of Bacillus Calmette-Guérin affect tr…
-
CLINICAL_TRIALS trial_result · 2026-03-13Clinical Trial Update: A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer [Phase 3]
Phase 3 study evaluating TAR-210 versus intravesical chemotherapy for high-risk non-muscle-invasive bladder cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer [Phase 1]
This document reports an ongoing Phase 1 clinical trial by the University of California, Davis evaluating PLZ4-coated paclitaxel-loaded mice…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial [NA]
A clinical trial compares a home-based physical activity program using a digital app to health education in patients with localized non-musc…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: IDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder Cancer [Phase 1]
Phase 1 clinical trial evaluating IO102-IO103 in combination with pembrolizumab for high-risk non-muscle invasive bladder cancer that is unr…
-
CLINICAL_TRIALS other · 2026-03-13Clinical Trial Update: A Study of HS-10566 in Patients With High-risk Non-muscle-invasive Bladder Cancer Who Are Ineligible for or Refuse Radical Cystectomy [Phase 1, Phase 2]
Clinical trial update notes that HS-10566 is being studied in high-risk non-muscle-invasive bladder cancer in Phase 1 and Phase 2. The study…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: A Study of NDV-01 (Sustained-release Gemcitabine-docetaxel) in Participants With Non-muscle Invasive Bladder Cancer [Phase 3]
Relmada Therapeutics is evaluating NDV-01, a sustained-release gemcitabine-docetaxel formulation, in Phase 3 for non-muscle invasive bladder…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants [Phase 3]
Phase 3 clinical trial update on combining durvalumab with BCG for adults with high-risk non-muscle invasive bladder cancer who are BCG-naïv…
-
CLINICAL_TRIALS trial_result · 2026-03-03Clinical Trial Update: Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC [Phase 4]
A Phase 4 trial comparing neoadjuvant short-term intensive chemoresection to standard adjuvant intravesical instillations in non-muscle inva…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Guiding Value of Urinary Tumor DNA Testing in Repeat Transurethral Resection of Non-Muscle-Invasive Bladder Cancer [NA]
This clinical trial update discusses the potential value of urinary tumor DNA testing for guiding repeat transurethral resection decisions i…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: The Study is to Evaluate the Safety and Tolerability of SPGL008 Alone or in Combination With BCG in the Patients With NMIBC, and to Determine the RP2D of SPGL008 Alone or in Combination With BCG.To Evaluate the Preliminary Efficacy of SPGL008 Alone or in Combination With BCG. [Phase 1, Phase 2]
A Phase 1/2 trial evaluating SPGL008 alone or with BCG for non-muscle invasive bladder cancer to assess safety, determine the RP2D, and expl…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: The Guiding Value of Liquid Biopsy Based on Urinary Tumor DNA/RNA in the Second Transurethral Resection of High-risk Non-muscle Invasive Bladder Cancer
This clinical trial update describes ongoing recruitment for a study assessing urinary tumor DNA/RNA–based liquid biopsy during a second tra…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Intravesical Gem/Doce in Patients With NMIBC [Phase 2]
Phase 2 clinical trial evaluating intravesical gemcitabine and docetaxel for non-muscle invasive bladder cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-20Clinical Trial Update: A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC [Phase 3]
Phase 3 trial evaluating intravesical SHR-1501 combined with BCG versus investigator-selected chemotherapy in patients with BCG-unresponsive…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating STM-416 in patients undergoing TURBT for recurrent non-muscle-invasive bladder cancer; recruitment is cu…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027) [Phase 1, Phase 2]
Merck is conducting a Phase 1/2 clinical trial of Sacituzumab Tirumotecan (MK-2870) for non-muscle invasive bladder cancer, and the study is…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Intravesical Chemotherapy in Combination With Systemic Pembrolizumab in NMIBC Unresponsive or Exposed to BCG Therapy [Phase 2]
Phase 2 clinical trial investigating intravesical chemotherapy in combination with systemic pembrolizumab for non-muscle-invasive bladder ca…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study to Determine Possible Effects of Apalutamide, Compared to Placebo, on EGFR Expression in Patients With Non-muscle Invasive Bladder Cancer [Phase 1]
Phase 1 trial to evaluate the potential effect of apalutamide on EGFR expression in non-muscle invasive bladder cancer; not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: CRUCIAL-R Study : Cruciferous Vegetables Dietary Regimen in NMIBC [NA]
The CRUCIAL-R study is evaluating a cruciferous vegetables dietary regimen for non-muscle-invasive bladder cancer, with the trial currently …
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Hydeal Cyst® Intravesical Instillations in Patients Treated With Intravesical Chemotherapy or Immunotherapy in Non-muscle Invasive Bladder Cancer [NA]
A clinical trial update for Hydeal Cyst intravesical instillations in non-muscle invasive bladder cancer patients previously treated with in…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Cruciferous Vegetable Eating Program for the Reduction of Cancer Recurrence and Progression in Patients With Non-muscle Invasive Bladder Cancer [Phase 2]
Phase 2 clinical trial evaluating whether a cruciferous vegetable eating program can reduce recurrence and progression in patients with non-…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 clinical trial update notes that intravesical instillation of TARA-002 for high-grade non-muscle invasive bladder cancer is curren…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve [Phase 1, Phase 2]
A Phase 1/2 study (LEGEND Study: EG-70) is recruiting to evaluate EG-70 in non-muscle invasive bladder cancer, including patients with carci…